Skip to Main Content

Author Details

Dushyantha Jayaweera
University of Miami, Miller School of Medicine
1977
91
28
PMIDPaper TitleJournal TitlePublished Year
36202365Predicting COVID-19 cases using SARS-CoV-2 RNA in air, surface swab and wastewater samples.Sci Total Environ2023
38022645Opioids exacerbate inflammation in people with well-controlled HIV.Front Immunol2023
37733308Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.N Engl J Med2023
37380088Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis.Am J Prev Med2023
37108729HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle MicroRNAs.Int J Mol Sci2023
36968959Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks.Open Forum Infect Dis2023
36633838Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA2023
34727754Predicting cardiovascular risk using a novel risk score in young and middle-age adults with HIV: associations with biomarkers and carotid atherosclerotic plaque.Int J STD AIDS2022
35785276Transformation of Amphiphilic Antiviral Drugs into New Dimensional Nanovesicles Structures.ACS Omega2022
36561174Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial.medRxiv2022
36044317The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial.Crit Care Med2022
36269852Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.JAMA2022
36299427Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial.medRxiv2022
35313580COVID-19 Prediction using Genomic Footprint of SARS-CoV-2 in Air, Surface Swab and Wastewater Samples.medRxiv2022
34932996Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Difference?Gastroenterology2022
34901997Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.JAMA Intern Med2022
32892296Heart Health and Behavior Change in HIV-Infected Individuals.AIDS Behav2021
33521067Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol.Front Cardiovasc Med2021
33566660Addressing COVID-19 in Resource-Poor Settings: Comparing the Experiences of Vietnam and Sri Lanka.Am J Public Health2021
33511300Demographic representation in clinical trials for cell-based therapy.Contemp Clin Trials Commun2021
33803162Perspectives on the Health Effects of Hurricanes: A Review and Challenges.Int J Environ Res Public Health2021
34409188Self-reported hepatitis C(HCV) testing among people living with human immunodeficiency virus (PLWH).Heliyon2021
34776801Overview of COVID-19 and the Liver.Gastroenterol Hepatol (N Y)2021
34592777Optimizing Identification of People Living with HIV from Electronic Medical Records: Computable Phenotype Development and Validation.Methods Inf Med2021
34192060Prioritizing studies of COVID-19 and lessons learned.J Clin Transl Sci2021
32511546Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study.medRxiv2020
32053682Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV.PLoS One2020
33294742Rejuvenation of Senescent Endothelial Progenitor Cells by Extracellular Vesicles Derived From Mesenchymal Stromal Cells.JACC Basic Transl Sci2020
32574296COVID19: A Systematic Approach to Early Identification and Healthcare Worker Protection.Front Public Health2020
32539586Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study.Otolaryngol Head Neck Surg2020
31603314Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus.ACS Nano2019
31439096Blood Pressure and Marijuana Use: Results from a Decade of NHANES Data.Am J Health Behav2019
29872540Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry.Cell Discov2018
27908889MicroRNA-146a Induces Lineage-Negative Bone Marrow Cell Apoptosis and Senescence by Targeting Polo-Like Kinase 2 Expression.Arterioscler Thromb Vasc Biol2017
29276699Zika Virus: An Emerging Global Health Threat.Front Cell Infect Microbiol2017
27266949Improving HCV cure rates in HIV-coinfected patients - a real-world perspective.Am J Manag Care2016
26196665Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.N Engl J Med2015
24070643Abuse and mental health concerns among HIV-infected Haitian women living in the United States.J Assoc Nurses AIDS Care2014
22328294Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.Liver Transpl2012
23504530Relationship of Oxidative Stress with HIV Disease Progression in HIV/HCV Co-infected and HIV Mono-infected Adults in Miami.Int J Biosci Biochem Bioinforma2012
23176566New therapeutic landscape of NNRTIs for treatment of HIV: a look at recent data.Expert Opin Pharmacother2012
22532465Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.J Antimicrob Chemother2012
22643470Disparities in HIV-treatment responses between Haitians, African Americans, and Hispanics living in Miami-Dade County, Florida.J Health Care Poor Underserved2012
22206504Efficacy and safety outcomes among treatment-experienced women and men treated with etravirine in gender, race and clinical experience.AIDS Res Hum Retroviruses2012
20500231Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.HIV Med2011
21819530Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.HIV Med2011
19800334MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.Gastroenterology2010
18618237Gender differences in medication management capacity in HIV infection: the role of health literacy and numeracy.AIDS Behav2009
20133268Virologic suppression, treatment adherence, and improved quality of life on a once-daily efavirenz-based regimen in treatment-Naïve HIV-1-infected patients over 96 weeks.HIV Clin Trials2009
19812449Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96.Antivir Ther2009
  • 1 - 50 of 91

Recommended Authors

Padua University Hospital
Career Start Year 2016
Number of shared co-authors 0
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 1
IRCCS-ISMETT
Career Start Year 2001
Number of shared co-authors 2
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 2
Yale School of Public Health
Career Start Year 1999
Number of shared co-authors 0
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 3
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 6
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 0
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 3
Hospital Universitario de Guadalajara
Career Start Year 1991
Number of shared co-authors 2
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 4
David Geffen School of Medicine, University of California los angeles
Career Start Year 1989
Number of shared co-authors 9
Hospital Clinico San Carlos-IdiSSC, Universidad Complutense
Career Start Year 1988
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 1988
Number of shared co-authors 3
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 4
La Paz University Hospital
Career Start Year 1988
Number of shared co-authors 2
University of California san francisco
Career Start Year 1988
Number of shared co-authors 4
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 4
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 4
VA Medical Center
Career Start Year 1986
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 2
University of Washington
Career Start Year 1984
Number of shared co-authors 4
Perelman School of Medicine, the University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 1
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 2
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 2
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1979
Number of shared co-authors 4

Collaborators

Johns Hopkins University School of Medicine
Co-authored papers 7
University of Minnesota
Co-authored papers 5
Duke University School of Medicine
Co-authored papers 5
Duke Clinical Research Institute and Duke University School of Medicine
Co-authored papers 5
Duke University
Co-authored papers 5
National Center for Advancing Translational Sciences
Co-authored papers 4
University of Pittsburgh
Co-authored papers 3
University of Florida
Co-authored papers 3
Duke Clinical Research Institute, Duke University
Co-authored papers 3
University of Minnesota
Co-authored papers 3
University of Colorado School of Medicine
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Co-authored papers 2
Dalla Lana School of Public Health, University of Toronto
Co-authored papers 2
Co-authored papers 2
Royal Infirmary
Co-authored papers 2
School of Public Health, Brown University
Co-authored papers 2
Co-authored papers 2
Lewis Katz School of Medicine at Temple University
Co-authored papers 2
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2
Duke University Medical Center
Co-authored papers 2
Duke University
Co-authored papers 2
Harvard T. H. Chan School of Public Health
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Weill Cornell Medical College, New York-Presbyterian Hospital
Co-authored papers 2
Co-authored papers 2
Foundation for the National Institutes of Health
Co-authored papers 2